More children are getting infected with COVID-19 in the second wave, and reports suggest that the third wave will hit them hard. India is likely to follow in the footsteps of countries like Canada and USA, which have approved vaccines for children. According to media reports, Bharat Biotech will be conducting Phase 3 trials of its vaccine for the age group 2-18 years.
Watch the video for more.
(Script by Geetika Sachdev; video edited by Nang Tanvi)